Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - Tengjun Biotechnology Corp. | f10k2016ex31ii_chinaherb.htm |
| EX-31.1 - CERTIFICATION - Tengjun Biotechnology Corp. | f10k2016ex31i_chinaherb.htm |
| 10-K - ANNUAL REPORT - Tengjun Biotechnology Corp. | f10k2016_chinaherbgroup.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of China Herb Group Holdings Corporation (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Qiuping Lu, chief executive officer and chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: March 27, 2017 | By: | /s/ Qiuping Lu |
Qiuping Lu Chief Executive Officer |
| Date: March 27, 2017 | By: | /s/ Qiuping Lu |
Qiuping Lu Chief
Financial Officer and Principal Financial |